Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 860

1.

The impact of motor symptoms on self-reported anxiety in Parkinson's disease.

Salazar RD, Le AM, Neargarder S, Cronin-Golomb A.

Parkinsonism Relat Disord. 2017 Jan 24. pii: S1353-8020(17)30026-3. doi: 10.1016/j.parkreldis.2017.01.011. [Epub ahead of print]

PMID:
28256435
2.

Validation of the PROMIS® measures of self-efficacy for managing chronic conditions.

Gruber-Baldini AL, Velozo C, Romero S, Shulman LM.

Qual Life Res. 2017 Feb 26. doi: 10.1007/s11136-017-1527-3. [Epub ahead of print]

PMID:
28239781
3.

Timing and Kinetics of Nonmotor Fluctuations in Advanced Parkinson's Disease.

Ossig C, Sippel D, Fauser M, Gandor F, Jost WH, Ebersbach G, Storch A.

J Parkinsons Dis. 2017 Feb 8. doi: 10.3233/JPD-160996. [Epub ahead of print]

PMID:
28222537
4.

Gut-brain axis: Role of lipids in the regulation of inflammation, pain and CNS diseases.

Russo R, Cristiano C, Avagliano C, De Caro C, La Rana G, Raso GM, Canani RB, Meli R, Calignano A.

Curr Med Chem. 2017 Feb 16. doi: 10.2174/0929867324666170216113756. [Epub ahead of print]

PMID:
28215162
5.

Association between dopaminergic dysfunction and anxiety in de novo Parkinson's disease.

Picillo M, Santangelo G, Erro R, Cozzolino A, Amboni M, Vitale C, Barone P, Pellecchia MT.

Parkinsonism Relat Disord. 2017 Feb 9. pii: S1353-8020(17)30058-5. doi: 10.1016/j.parkreldis.2017.02.010. [Epub ahead of print]

PMID:
28214265
6.

Gut microbiota: Implications in Parkinson's disease.

Parashar A, Udayabanu M.

Parkinsonism Relat Disord. 2017 Feb 7. pii: S1353-8020(17)30036-6. doi: 10.1016/j.parkreldis.2017.02.002. [Epub ahead of print] Review.

PMID:
28202372
7.

Cross-sectional and longitudinal associations of motor fluctuations and non-motor predominance with cerebrospinal τ and Aβ as well as dementia-risk in Parkinson's disease.

Modreanu R, Cerquera SC, Martí MJ, Ríos J, Sánchez-Gómez A, Cámara A, Fernández M, Compta Y.

J Neurol Sci. 2017 Feb 15;373:223-229. doi: 10.1016/j.jns.2016.12.064.

PMID:
28131192
8.

Neuropsychiatric symptoms, behavioural disorders, and quality of life in Parkinson's disease.

Balestrino R, Martinez-Martin P.

J Neurol Sci. 2017 Feb 15;373:173-178. doi: 10.1016/j.jns.2016.12.060. Review.

PMID:
28131182
9.

Side-of-onset of Parkinson's disease in relation to neuropsychological measures.

Modestino EJ, Amenechi C, Reinhofer A, O'Toole P.

Brain Behav. 2016 Oct 19;7(1):e00590. doi: 10.1002/brb3.590.

10.

Psychosocial difficulties in patients with Parkinson's disease.

Schiavolin S, Raggi A, Quintas R, Cerniauskaite M, Giovannetti AM, Covelli V, Romito L, Elia AE, Carella F, Soliveri P, Leonardi M.

Int J Rehabil Res. 2017 Jan 25. doi: 10.1097/MRR.0000000000000216. [Epub ahead of print]

PMID:
28125436
11.

Reprint of "Neuropsychiatric symptoms, behavioural disorders, and quality of life in Parkinson's disease".

Balestrino R, Martinez-Martin P.

J Neurol Sci. 2017 Mar 15;374:3-8. doi: 10.1016/j.jns.2017.01.026. Review.

PMID:
28109579
12.

Anxiety is associated with cognitive impairment in newly-diagnosed Parkinson's disease.

Dissanayaka NN, Lawson RA, Yarnall AJ, Duncan GW, Breen DP, Khoo TK, Barker RA, Burn DJ; ICICLE-PD study group..

Parkinsonism Relat Disord. 2017 Mar;36:63-68. doi: 10.1016/j.parkreldis.2017.01.001.

13.

Pathology of behavior in PD: What is known and what is not?

Ehgoetz Martens KA, Lewis SJ.

J Neurol Sci. 2017 Mar 15;374:9-16. doi: 10.1016/j.jns.2016.12.062. Review.

14.

Making the Quick Diagnosis: A Case of Neonatal Shock.

Gardiner M, Ruttan TK, Kienstra AJ, Wilkinson M.

J Emerg Med. 2016 Dec 13. pii: S0736-4679(16)30991-X. doi: 10.1016/j.jemermed.2016.11.003. [Epub ahead of print]

PMID:
27986330
15.

Hospital care for mental health and substance abuse conditions in Parkinson's disease.

Willis AW, Thibault DP, Schmidt PN, Dorsey ER, Weintraub D.

Mov Disord. 2016 Dec;31(12):1810-1819. doi: 10.1002/mds.26832.

PMID:
27943472
17.

Laughter is the best medicine: The Second City<sup>®</sup> improvisation as an intervention for Parkinson's disease.

Bega D, Palmentera P, Wagner A, Hovde M, Barish B, Kwasny MJ, Simuni T.

Parkinsonism Relat Disord. 2017 Jan;34:62-65. doi: 10.1016/j.parkreldis.2016.11.001.

PMID:
27836715
18.

Neuropsychiatric characteristics of GBA-associated Parkinson disease.

Swan M, Doan N, Ortega RA, Barrett M, Nichols W, Ozelius L, Soto-Valencia J, Boschung S, Deik A, Sarva H, Cabassa J, Johannes B, Raymond D, Marder K, Giladi N, Miravite J, Severt W, Sachdev R, Shanker V, Bressman S, Saunders-Pullman R.

J Neurol Sci. 2016 Nov 15;370:63-69. doi: 10.1016/j.jns.2016.08.059.

PMID:
27772789
19.

Oxidative Stress and the Central Nervous System.

Salim S.

J Pharmacol Exp Ther. 2017 Jan;360(1):201-205.

PMID:
27754930
20.

Shining light on the head: Photobiomodulation for brain disorders.

Hamblin MR.

BBA Clin. 2016 Oct 1;6:113-124. Review.

Supplemental Content

Loading ...
Support Center